Jane Street’s Akoya BioSciences AKYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-179,381
Closed -$233K 10687
2025
Q2
$233K Buy
179,381
+164,244
+1,085% +$198K ﹤0.01% 8296
2025
Q1
$21K Sell
15,137
-2,665
-15% -$5.83K ﹤0.01% 9148
2024
Q4
$40.8K Sell
17,802
-12,619
-41% -$33.4K ﹤0.01% 9019
2024
Q3
$82.7K Sell
30,421
-14,288
-32% -$34.9K ﹤0.01% 9053
2024
Q2
$105K Buy
44,709
+31,262
+232% +$99.7K ﹤0.01% 8713
2024
Q1
$63.1K Sell
13,447
-8,623
-39% -$44.8K ﹤0.01% 8685
2023
Q4
$108K Buy
+22,070
New +$91.7K ﹤0.01% 8547

Jane Street's AKYA Position: Q3 2025 in Review

Jane Street sold out of Akoya BioSciences (AKYA) in Q3 2025, closing a stake of 179,381 shares — an estimated $233K sold.

Jane Street first reported a position in AKYA in Q4 2023 and held it in 7 quarters. The position peaked at $233K in Q2 2025. 0 funds tracked by Wall St. Rank hold AKYA as of Q3 2025.

  • Jane Street reported no remaining Akoya BioSciences position as of Q3 2025 after selling out during the quarter.
  • Jane Street sold 179,381 Akoya BioSciences shares in Q3 2025, an estimated $233K.
  • Jane Street first reported a position in Akoya BioSciences in Q4 2023 and held it in 7 quarters.
  • Jane Street's Akoya BioSciences position peaked at $233K in Q2 2025.
  • 0 funds tracked by Wall St. Rank held Akoya BioSciences as of Q3 2025.

Based on Jane Street's 13F filing for Q3 2025, filed 14 Nov 2025.